Published in Prog Med Virol on January 01, 1981
Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet (1985) 13.47
Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science (1985) 8.53
The three column spine and its significance in the classification of acute thoracolumbar spinal injuries. Spine (Phila Pa 1976) (1984) 6.42
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68
First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet (1998) 4.08
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science (1985) 3.81
Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol (1989) 3.73
Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci U S A (1989) 3.66
Complications associated with pedicle screws. J Bone Joint Surg Am (1999) 3.41
Scheduling of revaccination against hepatitis B virus. Lancet (1991) 2.65
HTLV-I/II antibodies in French blood donors. Lancet (1990) 2.54
Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet (1986) 2.48
Acute thoracolumbar burst fractures in the absence of neurologic deficit. A comparison between operative and nonoperative treatment. Clin Orthop Relat Res (1984) 2.47
Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis (1999) 2.32
Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet (1981) 2.31
Molecular characterization of integrons in Acinetobacter baumannii: description of a hybrid class 2 integron. Antimicrob Agents Chemother (2000) 2.25
Heterogeneous bullous pemphigoid antibodies: detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol (1989) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
The surgical and medical perioperative complications of anterior spinal fusion surgery in the thoracic and lumbar spine in adults. A review of 1223 procedures. Spine (Phila Pa 1976) (1995) 2.22
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer (2002) 2.18
Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet (1986) 2.14
Characterization of Streptococcus agalactiae strains by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol (1995) 2.13
Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. J Hepatol (1994) 2.08
Spinal instability as defined by the three-column spine concept in acute spinal trauma. Clin Orthop Relat Res (1984) 2.02
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci U S A (1997) 1.99
Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet (1988) 1.95
Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med (1999) 1.92
New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science (1986) 1.91
Kinetics of delta antigen and delta antibody in acute delta hepatitis: evaluation with different enzyme immunoassays. J Clin Microbiol (1988) 1.87
High human malarial infectivity to laboratory-bred Anopheles gambiae in a village in Burkina Faso. Am J Trop Med Hyg (1993) 1.70
Sentinelle traces of an epidemic of acute gastroenteritis in France. Lancet (1995) 1.67
Relapse of herpes simplex encephalitis. J Child Neurol (1995) 1.66
Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol (1987) 1.63
Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J (1998) 1.63
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature (1984) 1.63
Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet (1975) 1.62
Characterization of the chromosomal aac(6')-Iz gene of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1999) 1.61
[An epidemiological study of purulent meningitis cases admitted to hospital in Dakar, 1970-1979]. Bull World Health Organ (1981) 1.61
Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology (1986) 1.59
Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59
Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science (1987) 1.58
Excision of hemivertebrae and wedge resection in the treatment of congenital scoliosis. J Bone Joint Surg Am (1995) 1.56
Role of superantigenic strains in the prognosis of community-acquired methicillin-susceptible Staphylococcus aureus bacteraemia. Clin Microbiol Infect (2007) 1.55
Evidence for activation of cellular immune responses in patients with acute hepatitis E. Indian J Gastroenterol (2002) 1.54
Postoperative deep wound infection in adults after posterior lumbosacral spine fusion with instrumentation: incidence and management. J Spinal Disord (2000) 1.52
Pneumococcal serotypes in West Africa. Lancet (1980) 1.51
Hepatitis delta virus infection in French male HBsAg-positive homosexuals. Hepatology (1989) 1.51
Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol (1995) 1.46
Emergence of meningococcal meningitis caused by W 135 subgroup in Africa. Lancet (1982) 1.46
Cross-sectional and longitudinal epidemiology of hepatitis B in Senegal. Prog Med Virol (1981) 1.45
Vaccination against meningococcus C. vaccinal coverage in the French target population. Med Mal Infect (2013) 1.45
New vectors for combinatorial deletions in yeast chromosomes and for gap-repair cloning using 'split-marker' recombination. Yeast (1996) 1.44
In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 1.44
Analysis of the upper thoracic curve in surgically treated idiopathic scoliosis. A new concept of the double thoracic curve pattern. Spine (Phila Pa 1976) (1993) 1.43
Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses (1996) 1.42
[Human papillomavirus prophylactic vaccines: stakes and perspectives]. Gynecol Obstet Fertil (2006) 1.41
Genetic characterization of a cryptic genospecies of Haemophilus causing urogenital and neonatal infections. J Clin Microbiol (1993) 1.41
CMV infection in the donor and increased kidney graft loss: impact of full HLA-I mismatch and posttransplantation CD8(+) cell reduction. Am J Transplant (2013) 1.40
[Transmission of hepatitis C viruses: certainties and hypotheses]. Presse Med (1995) 1.39
Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle. Virology (1997) 1.36
Reconstructive spine surgery in pediatric patients with major loss in vital capacity. J Pediatr Orthop (1996) 1.36
Spinal instrumentation without fusion for progressive scoliosis in young children. J Pediatr Orthop (1998) 1.35
Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast. Lancet (1987) 1.35
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. J Infect Dis (1986) 1.35
Integrons: an antibiotic resistance gene capture and expression system. Clin Chem Lab Med (2000) 1.32
Immunisation against hepatitis B in man. Lancet (1976) 1.31
HBsAG positive reactivity in man not due to hepatitis B virus. Lancet (1987) 1.30
Typing of urogenital, maternal, and neonatal isolates of Haemophilus influenzae and Haemophilus parainfluenzae in correlation with clinical source of isolation and evidence for a genital specificity of H. influenzae biotype IV. J Clin Microbiol (1989) 1.29
Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases. Chemotherapy (1981) 1.29
Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics (1992) 1.28
Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Arch Virol (1998) 1.28
Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol (1981) 1.26
Localization of hepatitis A antigen in marmoset organs during acute infection with hepatitis A virus. J Infect Dis (1978) 1.26